Molina Healthcare (MOH) CLO adds 138 shares under 2019 employee stock purchase plan

Rhea-AI Filing Summary

Molina Healthcare, Inc. Chief Legal Officer Jeff D. Barlow increased his direct stake through the company’s employee stock purchase plan. He acquired 138 shares of common stock on June 30, 2026 at a plan price of $147.51 per share, bringing his direct holdings to 67,313 shares.

The shares were bought under Molina’s 2019 Employee Stock Purchase Plan, which sets the purchase price at 85% of the lower closing price on January 1, 2026 or June 30, 2026, using a reference price of $173.54. Footnotes also show that a portion of his broader equity awards will vest in tranches from March 2027 through March 2029.

Insider Trade Summary

Net Buyer: 138 shares

Net Buy 1 txn

Insider Barlow Jeff D.

Role Chief Legal Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	138	$147.51	$20K

Holdings After Transaction: Common Stock — 67,313 shares (Direct)

Footnotes (3)

1. F1. The shares were acquired under the Molina Healthcare, Inc. 2019 Employee Stock Purchase Plan (the "ESPP").
2. F2. In accordance with the ESPP, the purchase price is 85% of the closing price of the Issuer's common stock on January 1, 2026 of $173.54 (which represents the lower market price of the Issuer's common stock as of (i) January 1, 2026, the first date of the ESPP offering period, and (ii) June 30, 2026, the last trading day of the offering period).
3. F3. The shares vest as follows: 7,296 shares on March 1, 2027; 6,193 shares on March 1, 2028; and 4,574 shares on March 1, 2029. The remaining shares are vested.

Key Figures

Shares acquired: 138 shares Purchase price: $147.51 per share Holdings after transaction: 67,313 shares +4 more

7 metrics

Shares acquired 138 shares Common stock acquired on June 30, 2026 under ESPP

Purchase price $147.51 per share ESPP acquisition price for 138 shares

Holdings after transaction 67,313 shares Direct common stock owned after June 30, 2026 acquisition

ESPP reference price $173.54 Closing price on January 1, 2026 used in ESPP formula

Vesting on March 1, 2027 7,296 shares Equity award vesting schedule disclosed in footnote

Vesting on March 1, 2028 6,193 shares Equity award vesting schedule disclosed in footnote

Vesting on March 1, 2029 4,574 shares Equity award vesting schedule disclosed in footnote

Key Terms

Employee Stock Purchase Plan, ESPP, vesting, closing price

4 terms

Employee Stock Purchase Plan financial

"The shares were acquired under the Molina Healthcare, Inc. 2019 Employee Stock Purchase Plan (the "ESPP")."

An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.

ESPP financial

"In accordance with the ESPP, the purchase price is 85% of the closing price..."

An Employee Stock Purchase Plan (ESPP) is a company program that lets employees buy the company’s shares at a reduced price, usually by setting aside a small portion of their pay over time. It matters to investors because it encourages employees to own part of the business—like giving staff a discounted membership— which can boost commitment and performance, while also potentially increasing the number of shares available and affecting shareholder value.

vesting financial

"The shares vest as follows: 7,296 shares on March 1, 2027; 6,193 shares on March 1, 2028; and 4,574 shares on March 1, 2029."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

closing price financial

"the purchase price is 85% of the closing price of the Issuer's common stock on January 1, 2026 of $173.54"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 04:47 PM Accepted by SEC EDGAR 07/02/2026 - 04:47 PM Learn about SEC filing dates

FAQ

What insider transaction did Molina Healthcare (MOH) report for Jeff D. Barlow?

Molina Healthcare reported that Chief Legal Officer Jeff D. Barlow acquired 138 shares of common stock on June 30, 2026. The shares were obtained through the company’s 2019 Employee Stock Purchase Plan as part of his compensation-related equity participation.

At what price did Jeff D. Barlow acquire Molina Healthcare (MOH) shares?

Jeff D. Barlow acquired 138 Molina Healthcare shares at $147.51 per share. The price was determined under the 2019 Employee Stock Purchase Plan, which uses 85% of the lower closing price between January 1, 2026 and June 30, 2026, referencing $173.54.

How many Molina Healthcare (MOH) shares does Jeff D. Barlow hold after this Form 4 transaction?

Following the June 30, 2026 transaction, Jeff D. Barlow directly holds 67,313 shares of Molina Healthcare common stock. This reflects his updated position after acquiring 138 shares through the company’s employee stock purchase plan in this reported period.

Was Jeff D. Barlow’s Molina Healthcare (MOH) share acquisition an open-market purchase?

The acquisition was not an open-market trade; it was made under Molina Healthcare’s 2019 Employee Stock Purchase Plan. Such plan-based purchases are compensation-related and follow pre-set pricing formulas rather than discretionary buying on the open market.

How is the purchase price determined under Molina Healthcare’s 2019 ESPP for MOH shares?

Under Molina Healthcare’s 2019 Employee Stock Purchase Plan, the purchase price equals 85% of the closing price on the first and last day of the offering period. For this period, the reference closing price disclosed was $173.54 on January 1, 2026.

What future vesting schedule is disclosed for Jeff D. Barlow’s Molina Healthcare (MOH) equity awards?

A footnote states that 7,296 shares vest on March 1, 2027, 6,193 shares vest on March 1, 2028, and 4,574 shares vest on March 1, 2029. The remaining shares from those awards are already vested at the time of this report.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Barlow Jeff D.

(Last) (First) (Middle)

200 OCEANGATE, SUITE 100

(Street)

LONG BEACH CALIFORNIA 90802

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/30/2026		A(1)		138	A	$147.51(2)	67,313(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were acquired under the Molina Healthcare, Inc. 2019 Employee Stock Purchase Plan (the "ESPP").

2. In accordance with the ESPP, the purchase price is 85% of the closing price of the Issuer's common stock on January 1, 2026 of $173.54 (which represents the lower market price of the Issuer's common stock as of (i) January 1, 2026, the first date of the ESPP offering period, and (ii) June 30, 2026, the last trading day of the offering period).

3. The shares vest as follows: 7,296 shares on March 1, 2027; 6,193 shares on March 1, 2028; and 4,574 shares on March 1, 2029. The remaining shares are vested.

Remarks:

	Jeff D. Barlow	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)